OncoCyte, which is developing blood-based tests to catch cancer early, announced Monday that its lung cancer diagnostic succeeded in a 300-patient study.
Novartis Chairman Joerg Reinhardt is talking down the chances of a smart lens project it began with Google yielding anything incredible in the next few years.
Prevencio unveiled promising results from a study investigating its multiprotein blood panel’s ability to predict the presence of obstructive coronary artery…
Takeda has teamed up with Cognition Kit to trial the use of an Apple Watch app to monitor people with depression.
Medrobotics has raised $20 million to develop a next-generation robotic surgery system and expand use of its existing platform into new indications.
Biotronik has received FDA approval for a bare-metal stent designed to treat coronary artery disease.
University of Michigan scientists have adapted a microscopy technique to accelerate and automate the analysis of brain tissue during tumor removal surgery.
Profusa and North Carolina State University's ASSIST Center have secured funding to co-develop a wearable wireless oxygen monitor.
PGDx has won a contract to develop a liquid assay for identifying patients who are likely to respond to checkpoint inhibitors such as Merck’s Keytruda.
Guardant Health and the University of Texas MD Anderson Cancer Center aim to to push liquid biopsy into the standard of care in cancer treatment.